GAL and neoplasm: In cancers like cervical, lung, melanoma, prostate, ovarian, thyroid, pancreatic, head–neck, bladder, uterine, and colorectal cancers, Gal‐1 is frequently overexpressed and plays a role in cancer progression by interacting with glycoconjugates within the tumor microenvironment.